Skip to content
777 Sourcing.

Capability

rapid design-to-clinic timelines

Suppliers
1
States & provinces
1
Countries
1

1 rapid design-to-clinic timelines supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

IASO THERAPEUTICS INC

EAST LANSING, MI

Iaso Therapeutics, Inc. is a start-up company spun out from Michigan State University, founded in 2018 by Dr. Xuefei Huang. It is dedicated to developing next generation vaccines to enhance human health and treat diseases, integrating precision synthetic antigens with a powerful mQβ VLP carrier to elicit robust, durable, and antigen-focused immunity. Its initial product offering is a disruptive new virus-like particle, mutant Qβ (mQβ), now sold by Fina Biosolutions.

mQβ VLP carrier technologysynthetic antigen vaccine platformsynthetic control for broad coverage and immune optimization

Compiled from public sources

Related capabilities

Other processes offered by the shops that list rapid design-to-clinic timelines.

Browse all capabilities